Nuvation Bio (NUVB) CFO exercises 40,000 share options and boosts holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nuvation Bio Inc. reports that Chief Financial Officer Philippe Sauvage exercised employee stock options covering 40,000 shares of Class A common stock on July 15, 2026 through two transactions at exercise prices of $1.97 and $2.17 per share. Corresponding option positions were reduced, while the acquired shares are held directly. Footnotes state that the reported common share balance includes 1,458 shares purchased through the employee stock purchase plan on May 19, 2026, and describe option grants that vest 25% on the one-year anniversaries of October 7, 2024 and February 28, 2025 and monthly over the following 36 months, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
40,000 shares exercised/converted
Mixed
4 txns
Insider
Sauvage Philippe
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 39,999 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 1 | $0.00 | -- |
| Exercise | Class A Common Stock | 39,999 | $2.17 | $87K |
| Exercise | Class A Common Stock | 1 | $1.97 | $1.97 |
Holdings After Transaction:
Stock Option (Right to Buy) — 662,333 shares (Direct);
Class A Common Stock — 54,130 shares (Direct)
Footnotes (1)
- Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026. Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Option vests as to 25% on the one year anniversary of February 28, 2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Key Figures
Shares acquired via option exercise: 40,000 shares
Exercise price (grant 1): $1.97 per share
Exercise price (grant 2): $2.17 per share
+4 more
7 metrics
Shares acquired via option exercise
40,000 shares
Total Class A common shares underlying options exercised on July 15, 2026
Exercise price (grant 1)
$1.97 per share
Exercise price for 1 share of Class A common stock
Exercise price (grant 2)
$2.17 per share
Exercise price for 39,999 shares of Class A common stock
Remaining options at $1.97
499,999 options
Stock options (right to buy) remaining after the $1.97 exercise
Remaining options at $2.17
662,333 options
Stock options (right to buy) remaining after the $2.17 exercise
Option expiration dates
2035-02-27 and 2034-10-06
Expiration dates for the two option grants exercised in part
ESPP shares included
1,458 shares
Shares purchased via employee stock purchase plan on May 19, 2026
Key Terms
Stock Option (Right to Buy), employee stock purchase plan, Class A Common Stock, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
employee stock purchase plan financial
"Includes 1,458 shares purchased through the issuer's employee stock purchase plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Class A Common Stock financial
"security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vesting financial
"Option vests as to 25% on the one year anniversary ... and monthly thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2035-02-27" and "2034-10-06" for option grants"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Nuvation Bio (NUVB) CFO Philippe Sauvage report in this Form 4?
CFO Philippe Sauvage reported exercising employee stock options for 40,000 shares of Nuvation Bio Class A common stock on July 15, 2026, at exercise prices of $1.97 and $2.17 per share, increasing his directly held shares.
What stock options remain for the Nuvation Bio (NUVB) CFO after these exercises?
After these transactions, one option grant shows 499,999 options remaining at a $1.97 exercise price, and another shows 662,333 options remaining at a $2.17 exercise price, each expiring in 2035 and 2034, respectively.
What do the vesting footnotes in the Nuvation Bio (NUVB) Form 4 indicate?
Footnotes state two option grants vest 25% on the one-year anniversaries of October 7, 2024 and February 28, 2025, then vest monthly over the following 36 months, contingent on the CFO’s continuous service with the company.